Global Home Infusion Therapy Market to Reach $77B by 2033, Driven by At-Home Care Demand

Global Home Infusion Therapy Market Overview 2025–2033

According to Renub Research Latest Report Home Infusion Therapy Market is projected to grow significantly over the next decade, reaching US$ 77.34 billion by 2033 from US$ 45.28 billion in 2024, at a CAGR of 6.13% from 2025 to 2033. Increasing prevalence of chronic illnesses, aging populations, technological developments in healthcare, and a growing preference for at-home care are the main drivers behind this growth.

Home infusion therapy enables patients to receive essential treatments such as drugs, fluids, or nutrients directly into their bloodstream via an intravenous (IV) line while staying in the comfort of their own home. It is particularly useful for patients with chronic conditions such as cancer, diabetes, or severe infections, as well as for those requiring pain management, hydration therapy, or long-term medication.

The appeal of home infusion therapy lies in its convenience, cost-effectiveness, and patient comfort, offering a viable alternative to hospital stays. Patients or caregivers are often trained by healthcare professionals to administer therapy safely, with medical supervision ensuring efficacy and adherence to protocols.

According to the Research Institute for Home Care (RIHC) 2023 Home Care Chartbook, there were 11,353 active home health agencies in the U.S. in 2022, reflecting a steady demand for home-based healthcare services. Coverage under Medicare and commercial insurance further supports the adoption of home infusion therapy, promoting financial accessibility and widespread adoption.

👉 Want to explore detailed market trends, segment insights, and forecasts? 🔗 Request Sample Report

Key Drivers of Home Infusion Therapy Market Growth

1. Increasing Need for Customized Infusion Services

As chronic diseases become more prevalent, there is a rising demand for personalized infusion therapies at home. Customized therapy reduces hospital dependency while improving patient outcomes. Specialty home infusion nursing services, such as Dynamic Access’s Dynamic Infusion, provide care for patients with multiple sclerosis, autoimmune disorders, and other long-term conditions, offering over 10,000 home visits annually across nine U.S. states.

2. Integration of Digital Health Tools

Digital health technologies are transforming home infusion therapy by enabling remote monitoring, real-time data sharing, and treatment adherence tracking. Patients can share therapy progress with healthcare providers, allowing for timely adjustments to treatment plans and reduced need for in-person consultations. For example, Moog’s CURLIN 8000 ambulatory infusion system, approved by the FDA in 2024, provides precise multi-therapy infusion capabilities and seamless connectivity with CURLIN RxManager, improving safety and control for both patients and pharmacists.

3. Adoption of Cutting-Edge Infusion Technology

Technological innovation is enhancing safety, efficiency, and precision in home infusion therapy. Smart infusion pumps, safety software, and automated monitoring systems reduce medication errors, ease caregiver workload, and support integration with digital platforms. Baxter’s Novum IQ large-volume infusion pump and Dose IQ Safety Software, approved by the FDA in 2024, exemplify advancements that improve home-based patient care while enhancing clinician efficiency and safety.

Challenges Facing the Home Infusion Therapy Market

1. Limited Reimbursement in Developing Markets

The adoption of home infusion therapy is constrained in developing nations due to lack of standardized reimbursement policies. Out-of-pocket expenses in countries like China and India remain high, limiting patient access. Combined with a shortage of trained professionals and few established home infusion providers, this slows market expansion in these regions.

2. Regulatory Compliance Complexity

The home infusion therapy market must navigate complex, region-specific regulatory frameworks, covering drug administration, patient safety, and reimbursement rules. Compliance challenges may hinder consistent, high-quality care delivery, particularly for providers seeking to expand services across multiple regions.

Regional Market Insights

North America:

North America leads the global home infusion therapy market due to advanced healthcare infrastructure, favorable reimbursement policies, and high demand for home-based care. The U.S. market is bolstered by technological innovations, a growing aging population, and strategic acquisitions. For example, Memorial Hermann Health System’s investment in KabaFusion in 2023 expanded home infusion services nationwide. Additionally, Amedisys’s USD 3.6 billion merger with Optum Inc. in 2023 positions it to offer more extensive home infusion services, reinforcing U.S. market leadership.

Europe:

Germany, France, and the U.K. drive European market growth due to an aging population, rising chronic illnesses, and advanced healthcare infrastructure. Home infusion therapy reimbursement policies and technological adoption enhance patient safety and monitoring. Despite challenges such as complex regulations and workforce shortages, demand for home-based treatment continues to rise across the region.

Asia-Pacific:

Asia-Pacific is a rapidly growing market, led by China, India, and Japan. Expanding middle-class populations, increasing healthcare access, and rising chronic disease prevalence fuel adoption. While challenges include limited infrastructure, workforce shortages, and reimbursement issues, awareness of home-based care benefits and technological improvements are expected to drive significant growth in the coming years.

Latin America and Middle East & Africa:

Markets in Brazil, Mexico, Saudi Arabia, and the UAE are slowly expanding due to growing healthcare awareness, rising chronic disease rates, and government initiatives. However, regulatory barriers, limited skilled personnel, and low patient awareness pose challenges. Saudi Arabia, for instance, demonstrates strong potential due to government healthcare programs and technological advancement, but scaling remains gradual.

👉 For deeper analysis, detailed segment data, and company insights: 🔗 Request Customization Report

Market Segmentation

By Product:

Infusion Pumps

Intravenous (IV) Sets

IV Cannulas

Needleless Connectors

By Application:

Anti-Infective Therapy

Hydration Therapy

Chemotherapy

Enteral Nutrition

Parenteral Nutrition

Specialty Pharmaceuticals

Others

By Country/Region:

North America: U.S., Canada

Europe: Germany, France, U.K., Italy, Spain, Belgium, Netherlands, Turkey

Asia-Pacific: China, Japan, India, South Korea, Thailand, Malaysia, Indonesia, Australia, New Zealand

Latin America: Brazil, Mexico, Argentina

Middle East & Africa: Saudi Arabia, UAE, South Africa

Key Players and Competitive Landscape

The home infusion therapy market features leading global players focusing on product innovation, strategic acquisitions, and expansion of home-based services. Key companies include:

Pfizer Inc. – Offers a broad portfolio of specialty pharmaceuticals for home infusion.

Smith & Nephew plc – Focuses on advanced infusion devices and training programs.

Terumo Corporation – Provides IV sets, cannulas, and smart infusion solutions.

Johnson & Johnson Services, Inc. – Develops innovative infusion pumps and safety solutions.

Becton, Dickinson and Company – Supplies needleless connectors and IV administration sets.

Baxter International Inc. – Leads with smart infusion pumps, safety software, and integrated digital monitoring.

ICU Medical – Provides specialized infusion systems for chemotherapy and anti-infective therapies.

Eli Lilly and Company – Focuses on biologics and specialty drug infusion for chronic diseases.

These players actively invest in R&D, strategic collaborations, and mergers and acquisitions to enhance homecare capabilities and expand geographically.

Future Outlook

The home infusion therapy market is expected to maintain steady growth, driven by chronic illness prevalence, technological advancements, and patient preference for at-home care. Digital health integration, smart infusion technology, and personalized care services will continue to improve patient outcomes and healthcare efficiency.

While challenges such as reimbursement limitations, regulatory complexity, and workforce shortages persist, market expansion in emerging regions presents a significant opportunity. Governments, healthcare providers, and private companies are increasingly emphasizing home-based care as a cost-effective and patient-centric solution, ensuring the market’s robust growth trajectory through 2033.

The market’s future will likely witness greater adoption of connected devices, real-time monitoring tools, and intelligent infusion pumps, allowing patients and caregivers to manage complex therapies safely and effectively at home.

Note: If you need details, data, or insights not covered in this report, we are glad to assist. Through our customization service, we will collect and deliver the information you require, tailored to your specific needs. Share your requirements with us, and we will update the report to align with your expectations.